Navigation Links
BELLUS HEALTH reports results for first quarter of fiscal 2008
Date:5/5/2008

LAVAL, QC, May 5 /PRNewswire-FirstCall/ - BELLUS Health Inc. (NASDAQ: BLUS; TSX: BLU, formerly known as Neurochem Inc.) reported results for the first quarter ended March 31, 2008. The Company reported a net loss of $12,902,000 ($0.26 per share) for the quarter, compared to $21,016,000 ($0.54 per share) for the same period the previous year. The decrease in the net loss is mainly due to a reduction in research and development (R&D) expenses, before research tax credits and grants, which amounted to $8,780,000 this quarter, compared to $16,828,000 for the same period the previous year. The decrease in R&D expenses is mainly attributable to a reduction in expenses incurred in relation to the development of tramiprosate (ALZHEMED(TM); homotaurine) for the treatment of Alzheimer's disease, following the Company's decision in November 2007 to terminate the tramiprosate (ALZHEMED(TM)) pharmaceutical drug development program and to take steps to commercialize homotaurine (VIVIMIND(TM)) as a branded nutraceutical.

As at March 31, 2008, the Company had available cash, cash equivalents and marketable securities of $43,448,000, compared to $58,672,000 at December 31, 2007. BELLUS Health is expecting to further reduce its burn rate during fiscal 2008.

Consolidated Financial Results Highlights

The shareholders of Neurochem Inc. approved the change of its name to "BELLUS Health Inc." at the Annual and Special Shareholders' Meeting on April 15, 2008. The new stock ticker symbols, BLUS (NASDAQ) and BLU (TSX), came into use on April 21, 2008.

The Management's Discussion and Analysis (MD&A) provides a review of the Company's operations, performance and financial position for the quarter ended March 31, 2008, compared with the quarter ended March 31, 2007. It should be read in conjunction with the Company's unaudited consolidated financial statements for the three-month period ended March 31, 2008, as well as the Company's audited consolidated financ
'/>"/>

SOURCE BELLUS Health Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine news :

1. At Annual and Special Meeting of Shareholders - Neurochem to officially adopt new name - BELLUS Health - And to provide update on programs including first new natural health product, VIVIMIND(TM)
2. Penn study finds pro-death proteins required to regulate healthy immune function
3. UCLA researchers identify markers that may predict diabetes in still-healthy people
4. Air pollution linked to cardiovascular risk indices in healthy young adults
5. More proof needed of safety and quality of electronic personal health records
6. Health care incentive model offers collaborative approach
7. Loneliness is bad for your health
8. Mailman School of Public Health study examines link between racial discrimination and substance use
9. Green Tea May Brew Up Healthier Skin
10. For Health Info, Women Often Turn to the Web
11. Record Number of Americans Lack Health Insurance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)...ewswire/ --Physicians Practice and St. Mary Medica...hysicians and their staff more time to devote to p...ram designed to help doctors in the Long Beach-Tor...onsuming issues of managing a busy practice. Throu... use Physicians Practice,s extensive resources to ...
(Date:1/8/2009)...ers at Oregon Health & Science University,s School... a novel function of the peptide known as Nerve Gr...inal nerve. The trigeminal nerve provides the sign...l pain, and pain associated with temporomandibular...er neuropathic and inflammatory conditions. , Th...
(Date:1/8/2009)...8 Davis Vision, Inc., headquartere...onal vice president of sales for its Northern divi...Ehrle will contribute to Davis Vision,s national n...trong asset to Davis Vision,s sales management tea...president and chief marketing officer. "Mike bring...
(Date:1/8/2009)...locks Potential, Encourages Growth and Enrichment ...e Senior Living, http:// www.brookdaleliving....ving communities in the United States, is pleased ...rlong life enrichment and dining program opportuni...unities, Celebrations offers themed experiences, s...
Breaking Medicine News(10 mins):Health News:Physicians Practice and St. Mary Medical Center Partner to Improve Patient Care in Long Beach, CA 2Health News:Physicians Practice and St. Mary Medical Center Partner to Improve Patient Care in Long Beach, CA 3Health News:Davis Vision, Inc. Names Michael Ehrle Divisional Vice President of Sales 2Health News:Senior Living Provider Invites Residents to Dream. Dare. Discover! 2Health News:Senior Living Provider Invites Residents to Dream. Dare. Discover! 3
...nts a molecule related to tetracycline can aid sto...niversity of Iowa have been looking at a new drug ... antibiotic tetracycline. In a series of experimen...rounding a tumour, making that tumour less likely ...
... a recent study that women who are obese in middle...ries. Recent research has marked to the carotid ar...alth of the arteries that serve the heart. If the ...ckened, then it's more likely the person will suff...
... is observed that thalidomide is effective as firs...a patients when combined with a standard chemother...hester, Minn.// gave 60 newly diagnosed myeloma pa...tic steroid dexamethasone. Results show 55 percent...
..., reveal people with GERD, gastro-esophageal reflu...e more likely than others without these conditions... and poor sleep quality.// Researchers from Pennsy...adults, who reported having risk factors for sleep...
Other Medicine News:
(Date:1/7/2009)...oducts in Development Based On Osteotech,s Proprie...l BioRegeneration; FDA Filing Anticipated in Third...ewswire-FirstCall/ -- Osteotech, Inc. (Nasdaq: ...c products for regenerative healing, announced tod...for its DuraTech(TM) BioRegeneration Matrix. The f...
(Date:1/6/2009)... 6 In recent controlled studies co...phis , scientists found that the patented ingredie...d only proven ingredient to increase levels of nit...od nitrate/nitrate (NOx) in human subjects. , ,... increase in blood flow to the skeletal muscles. ...
(Date:1/6/2009)...January 6 , - Ear...ation Until,December 2011 , - Expansion of...y,Discovery in Ophthalmology , - Revised C...n,Sublicenses to a Third Party , ExonHit... reinforcement,of its existing drug discovery col...
(Date:12/30/2008)... The Coalition for 21st...ition filed by Genentech, Inc. on December 5, 2008...to offer diagnostic tests to physicians and patien...y tests, would harm patient care and rests on flaw...tion,s mission is to encourage the research, devel...
Breaking Medicine Technology:Osteotech Initiates Pivotal Clinical Trial for DuraTech(TM) BioRegeneration Matrix 2Osteotech Initiates Pivotal Clinical Trial for DuraTech(TM) BioRegeneration Matrix 3US Testing Proves Glyc'n Go(TM) Increases NO in the Blood Stream 2ExonHit Therapeutics Expands Strategic Collaboration With Allergan 2ExonHit Therapeutics Expands Strategic Collaboration With Allergan 3ExonHit Therapeutics Expands Strategic Collaboration With Allergan 4Coalition for 21st Century Medicine Issues Statement in Opposition of Genentech Petition to Restrict Lab Use of Diagnostic Tests for Physicians and Patients 2Coalition for 21st Century Medicine Issues Statement in Opposition of Genentech Petition to Restrict Lab Use of Diagnostic Tests for Physicians and Patients 3Coalition for 21st Century Medicine Issues Statement in Opposition of Genentech Petition to Restrict Lab Use of Diagnostic Tests for Physicians and Patients 4HHS Secretary Leavitt Announces Members of the New Interagency Autism Coordinating Committee 7043 1HHS Secretary Leavitt Announces Members of the New Interagency Autism Coordinating Committee 7043 2HHS Secretary Leavitt Announces Members of the New Interagency Autism Coordinating Committee 7043 3HHS Secretary Leavitt Announces Members of the New Interagency Autism Coordinating Committee 7043 4HHS Secretary Leavitt Announces Members of the New Interagency Autism Coordinating Committee 7043 5HHS Secretary Leavitt Announces Members of the New Interagency Autism Coordinating Committee 7043 6Lung Cancer Alliance Georgia Issues Second Annual State Specific Report Card on Lung Cancer 7038 1Lung Cancer Alliance Georgia Issues Second Annual State Specific Report Card on Lung Cancer 7038 2Lung Cancer Alliance Georgia Issues Second Annual State Specific Report Card on Lung Cancer 7038 3Wiley Blackwell to relaunch InfoPOEMs with InfoRetriever 7033 1Wiley Blackwell to relaunch InfoPOEMs with InfoRetriever 7033 2US Preventive Medicine 28R 29 Says Study on Heart Disease related Deaths Demonstrates Need for Preventive Medical Care 7030 1US Preventive Medicine 28R 29 Says Study on Heart Disease related Deaths Demonstrates Need for Preventive Medical Care 7030 2US Preventive Medicine 28R 29 Says Study on Heart Disease related Deaths Demonstrates Need for Preventive Medical Care 7030 3
...e,20, 2007 --- Millipore Corporation today announc...neural stem cell lines. The,research was conducte...llege London and ReNeuron Group plc, whose ReNcell...ed in 2006. ,The data will be presented by Dr. Vi ...ipore’s Bioprocess Division, in,a technology...
..., 2007 /PRNewswire-FirstCall/ - SemBioSys,Genetics...olio of,therapeutic proteins for metabolic and car...be presenting a scientific poster and,abstract at ...tes,Association (ADA) in Chicago. The Company,s po...evelopment of a highly-scalable, low,cost source o...
Other Medicine Technology:Millipore Corporation Announces New ReNcell Data from Collaboration,with ReNeuron 2Millipore Corporation Announces New ReNcell Data from Collaboration,with ReNeuron 3Millipore Corporation Announces New ReNcell Data from Collaboration,with ReNeuron 4SemBioSys to present new data at American Diabetes Association,annual meeting 2SemBioSys to present new data at American Diabetes Association,annual meeting 3
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Standard type 1/1 (mm), opening width 9.0 mm and length 8 mm.
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Standard type 1/1 (mm), opening width 8.0 mm and length 7 mm.
The BacT/Alert 3D Select Link is a state of the art, automated microbial detection system that integrates blood, sterile body fluid and mycobacteria culturing. This system is useful when patient data
The Vitek is a completely automated instrument that offers Rapid results (with an average of 2 - 6 hour same day turnaround), random or batch processing and a quality control module. It is used for b
Medicine Products: